Trends toward mesangial expansion appeared in most of the STZ-treated mice, and linagliptin ameliorated these trends only in mice with normal levels of G6PD (S5 and S6 Figs), but not in mice with G6PD deficiency. Here, G6PD is linked to hyperinsulinemic hypoglycemia, familial, 4.